key: cord-1041257-bftrc37n
authors: Rogawski McQuade, Elizabeth T.; Guertin, Kristin A.; Becker, Lea; Operario, Darwin; Gratz, Jean; Guan, Dave; Khan, Fauzia; White, Jennifer; McMurry, Timothy L.; Shah, Bhruga; Garofalo, Stephanie; Southerland, Matt; Bear, Kelly; Brush, John; Allen, Cynthia; Frayser, Amy; Vokes, Rebecca; Pershad, Rashmi; Peake, Lilian; deFilippi, Christopher; Barackman, Kathleen; Bearman, Gonzalo; Bidanset, Andrea; Farrell, Francis; Trump, David; Houpt, Eric R.
title: Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia
date: 2021-02-08
journal: JAMA Netw Open
DOI: 10.1001/jamanetworkopen.2020.35234
sha: 3ddf453a35143197a99702976fb8ccb550b4ff75
doc_id: 1041257
cord_uid: bftrc37n

IMPORTANCE: Data from seroepidemiologic surveys measuring severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure in diverse communities and ascertaining risk factors associated with infection are important to guide future prevention strategies. OBJECTIVE: To assess the prevalence of previous SARS-CoV-2 infection across Virginia and the risk factors associated with infection after the first wave of coronavirus disease 2019 (COVID-19) infections in the US. DESIGN, SETTING, AND PARTICIPANTS: In this statewide cross-sectional surveillance study, 4675 adult outpatients presenting for health care not associated with COVID-19 in Virginia between June 1 and August 14, 2020, were recruited to participate in a questionnaire and receive venipuncture to assess SARS-CoV-2 serology. Eligibility was stratified to meet age, race, and ethnicity quotas that matched regional demographic profiles. MAIN OUTCOMES AND MEASURES: The main outcome was SARS-CoV-2 seropositivity, as measured by the Abbott SARS-CoV-2 immunoglobulin G assay. RESULTS: Among 4675 adult outpatients (mean [SD] age, 48.8 [16.9] years; 3119 women [66.7%]; 3098 White [66.3%] and 4279 non-Hispanic [91.5%] individuals) presenting for non–COVID-19–associated health care across Virginia, the weighted seroprevalence was 2.4% (95% CI, 1.8%-3.1%) and ranged from 0% to 20% by zip code. Seroprevalence was notably higher among participants who were Hispanic (10.2%; 95% CI, 6.1%-14.3%), residing in the northern region (4.4%; 95% CI, 2.8%-6.1%), aged 40 to 49 years (4.4%; 95% CI, 1.8%-7.1%), and uninsured (5.9%; 95% CI, 1.5%-10.3%). Higher seroprevalence was associated with Hispanic ethnicity (adjusted odds ratio [aOR], 3.56; 95% CI, 1.76-7.21), residence in a multifamily unit (aOR, 2.55; 95% CI, 1.25-5.22), and contact with an individual with confirmed COVID-19 infection (aOR, 4.33; 95% CI, 1.77-10.58). The sensitivity of serology results was 94% (95% CI, 70%-100%) among those who reported receiving a previous polymerase chain reaction test for COVID-19 infection. Among 101 participants with seropositive results, 67 individuals (66.3%) were estimated to have asymptomatic infection. These data suggested a total estimated COVID-19 burden that was 2.8-fold higher than that ascertained by PCR-positive case counts. CONCLUSIONS AND RELEVANCE: This large statewide serologic study estimated that 2.4% of adults in Virginia had exposure to SARS-CoV-2, which was 2.8-fold higher than confirmed case counts. Hispanic ethnicity, residence in a multifamily unit, and contact with an individual with confirmed COVID-19 infection were significant risk factors associated with exposure. Most infections were asymptomatic. As of August 2020, the population in Virginia remained largely immunologically naive to the virus.

participants did not know or data was missing (< 1%); Data were missing for health insurance (n=76), reason for presenting to clinic (n=3), high risk health condition (n=35), number of adults in household (n=4), number of children in household (n=5), work outside the home (n=3), work in a hospital, doctor's office, outpatient clinic, long-term care facility, or assisted living facility (n=3), work in an essential service (n=11), contact with a COVID+ individual (n=3), travel outside the country (n=4), travel outside the state (n=4), self-reported concern (n=3), self-reported carefulness (n=3) b Medicaid includes FAMIS, Virginia's health insurance program for children c includes Tricare or Veterans Administration d no patients were presenting for acute COVID-19 illness; reason for presenting to clinic missing for n=3 participants e diabetes, lung disease (including moderate to severe asthma), a severe heart condition, kidney disease, liver disease, or immunocompromise

Enrollment rate by zip code. The zip code is colored based on the number of individuals enrolled per 100,000 population in the zip code. (B) Population of each zip code in Virginia